Published in Virology on September 15, 2001
Poxvirus tropism. Nat Rev Microbiol (2005) 3.07
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog (2009) 2.24
The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol (2004) 2.10
NF-kappaB and virus infection: who controls whom. EMBO J (2003) 2.08
NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev (2002) 1.97
Role of the serine-threonine kinase PAK-1 in myxoma virus replication. J Virol (2003) 1.69
Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J Virol (2004) 1.65
Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun (2002) 1.65
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Poxvirus immunomodulatory strategies: current perspectives. J Virol (2003) 1.52
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses. J Virol (2007) 1.50
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proc Natl Acad Sci U S A (2008) 1.31
Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells. J Virol (2006) 1.26
A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation. J Virol (2004) 1.26
Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression. J Virol (2009) 1.14
Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells. J Virol (2006) 1.14
Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo. BMC Immunol (2008) 1.12
Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol (2006) 1.12
The Listeria monocytogenes InlC protein interferes with innate immune responses by targeting the I{kappa}B kinase subunit IKK{alpha}. Proc Natl Acad Sci U S A (2010) 1.11
Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis. Infect Immun (2005) 1.01
Cowpox virus expresses a novel ankyrin repeat NF-kappaB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesis. J Virol (2009) 1.00
Poxvirus MC160 protein utilizes multiple mechanisms to inhibit NF-kappaB activation mediated via components of the tumor necrosis factor receptor 1 signal transduction pathway. J Virol (2009) 0.95
The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells. BMC Biochem (2012) 0.90
The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence. J Virol (2011) 0.89
Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation. J Virol (2013) 0.85
Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection. Virology (2008) 0.84
Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection. Virology (2011) 0.81
Early viral protein synthesis is necessary for NF-kappaB activation in modified vaccinia Ankara (MVA)-infected 293 T fibroblast cells. Virology (2009) 0.80
A vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB. J Virol (2010) 0.80
Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation. J Gen Virol (2010) 0.80
EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence. PLoS Pathog (2014) 0.80
Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses. J Virol (2014) 0.78
Role of nuclear factor-κB in oxidative stress associated with rabies virus infection of adult rat dorsal root ganglion neurons. J Virol (2012) 0.77
Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells. Leuk Res (2010) 0.76
Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector. J Virol (2011) 0.76
The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation. J Virol (2012) 0.75
Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus. Virology (2012) 0.75
Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell (1992) 5.54
Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem (1994) 2.21
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell (1992) 2.19
Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A (1996) 1.90
Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J Biol Chem (1995) 1.88
Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc Natl Acad Sci U S A (1986) 1.85
Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology (1997) 1.75
A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells. Proc Natl Acad Sci U S A (1988) 1.72
Messenger RNAs of a strongly-expressed late gene of cowpox virus contain 5'-terminal poly(A) sequences. EMBO J (1987) 1.62
Isolation of cowpox virus A-type inclusions and characterization of their major protein component. Virology (1986) 1.57
Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology (1994) 1.47
Spontaneous deletions and duplications of sequences in the genome of cowpox virus. Proc Natl Acad Sci U S A (1984) 1.44
High-level synthesis of biologically active reovirus protein sigma 1 in a mammalian expression vector system. Virology (1988) 1.37
A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc Natl Acad Sci U S A (1998) 1.34
Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology (1989) 1.21
Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology (1996) 1.17
The second-largest subunit of the poxvirus RNA polymerase is similar to the corresponding subunits of procaryotic and eucaryotic RNA polymerases. J Virol (1989) 1.16
Vaccinia virus directs the synthesis of early mRNAs containing 5' poly(A) sequences. Proc Natl Acad Sci U S A (1990) 1.07
Sequence at both termini of the 10 genes of reovirus serotype 3 (strain Dearing). Virology (1982) 1.01
Transcription of orthopoxvirus telomeres at late times during infection. Virology (1990) 1.00
Sequence of terminal regions of cowpox virus DNA: arrangement of repeated and unique sequence elements. Proc Natl Acad Sci U S A (1982) 0.98
The mode of death of pig kidney cells infected with cowpox virus is governed by the expression of the crmA gene. Virology (1996) 0.95
Transcription of a poxvirus early gene is regulated both by a short promoter element and by a transcriptional termination signal controlling transcriptional interference. J Virol (1989) 0.89
Transcription of the terminal loop region of vaccinia virus DNA is initiated from the telomere sequences directing DNA resolution. Virology (1991) 0.85
The eukaryotic translation initiation factor 4E is not modified during the course of vaccinia virus replication. Virology (1992) 0.85
Site-specific RNA cleavage generates the 3' end of a poxvirus late mRNA. Proc Natl Acad Sci U S A (1992) 0.85
Cloning of the terminal loop of vaccinia virus DNA. Virology (1983) 0.84
Fine structure mapping and phenotypic analysis of five temperature-sensitive mutations in the second largest subunit of vaccinia virus DNA-dependent RNA polymerase. Virology (1990) 0.83
Human IL-1 beta processing and secretion in recombinant baculovirus-infected Sf9 cells is blocked by the cowpox virus serpin crmA. J Immunol (1995) 0.80
Tandemly repeated sequences are present at the ends of the DNA of raccoonpox virus. Virology (1987) 0.80
A 43-nucleotide RNA cis-acting element governs the site-specific formation of the 3' end of a poxvirus late mRNA. Virology (1999) 0.80
Virulence genes of poxviruses and reoviruses. Vaccine (1988) 0.75